Profile
Kevin Chaplin has held positions as CEO at Kardium, Inc. since 2008 and as Director at LifeSciences British Columbia since 2021.
Kevin Chaplin active positions
Companies | Position | Start |
---|---|---|
Kardium, Inc.
Kardium, Inc. Medical SpecialtiesHealth Technology Kardium, Inc. develops groundbreaking medical devices. It offers treatment for atrial fibrillation. The company was founded by Dan Gelbart in 2007 and is headquartered in Burnaby, Canada. | Chief Executive Officer | 2007-12-31 |
LifeSciences British Columbia
LifeSciences British Columbia BiotechnologyHealth Technology LifeSciences British Columbia is a non-profit organization, which engages in supporting and representing the life science community through leadership, investment, advocacy, and promotion. It ensures that no life sciences sector is working in isolation and that all sectors come together in a comprehensive, complementary, and coordinated fashion. The company is headquartered in Vancouver, Canada. | Director/Board Member | 2021-09-15 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Kardium, Inc.
Kardium, Inc. Medical SpecialtiesHealth Technology Kardium, Inc. develops groundbreaking medical devices. It offers treatment for atrial fibrillation. The company was founded by Dan Gelbart in 2007 and is headquartered in Burnaby, Canada. | Health Technology |
LifeSciences British Columbia
LifeSciences British Columbia BiotechnologyHealth Technology LifeSciences British Columbia is a non-profit organization, which engages in supporting and representing the life science community through leadership, investment, advocacy, and promotion. It ensures that no life sciences sector is working in isolation and that all sectors come together in a comprehensive, complementary, and coordinated fashion. The company is headquartered in Vancouver, Canada. | Health Technology |
- Stock Market
- Insiders
- Kevin Chaplin